In previous studies using the Weisenberger panel, CIMP-positive status suggested good patient outcome in KRAS wild-type or MSI CRC [28, 30], but a poor prognosis in rectal cancer or CRC with chromosomal instability [30, 31]. The gene discussed is KRAS; the disease is colorectal carcinoma.